My Gene Counsel
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Solutions
    • Genetic Counselor Multiplier
    • Living Lab Reports
    • One-Stop Program
  • Media
    • Genetic Journal
    • News
    • Press Releases
    • Multimedia
    • Publications
    • Career Resources
    • Case Series
  • About Us
  • Login
Select Page
Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers

Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers

by Danielle Bonadies | Jan 4, 2023 | News

In 2022, many new therapies and tests for cancer were approved, but a significant number of patients are still not receiving appropriate therapies. Suboptimal testing paradigms, reimbursement issues and physicians’ inability to keep up with rapidly advancing...

Recent Posts

  • Looking Back on the 10-year Anniversary of the SCOTUS Decision
  • Genetic Testing Challenges in Oncology: Karyotype, Germline Clues in Somatic Diagnosis Lost in Translation
  • Genetic Testing Challenges in Oncology: Patient with Pending Bill has BRCA1 Result Withheld
  • Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers
  • NSGC 2022 Poster Presentation

Archives

  • About Us
  • One-Stop Solution
  • Living Lab Reports®
  • Media
  • Genetic Journal Blog
  • Career Resources
  • Population Studies
  • Healthcare Systems
  • Precision Medicine Partners
  • Contact Us
  • FAQs
  • Privacy Policy

The My Gene Counsel portal and website should not be construed, directly or indirectly, as the practice of medicine or dispensing of medical services by My Gene Counsel or its Partners.

My Gene Counsel   ©